The full form of Cipla is Chemical, Industrial & Pharmaceutical Laboratories. It’s used on Business ,Companies & Corporations in India

Cipla is a leading pharmaceutical from India with presence across the world. It was established in 1935 as Chemical Industrial & Pharmaceutical Laboratories Ltd and changed to its current name in 1984. The company has a vast portfolio with more than 1,500 products in the market. The company’s business is divided into three strategic units – APIs, respiratory and Cipla Global Access. Its largest market is India, followed by Africa and North America. Company’s total revenue reached Rs. 17,132 crore (US$ 2.43 billion) in FY20.

Company Website: www.cipla.com

As of 17 September 2014, its market capitalisation was ₹49,611.58 crore (equivalent to ₹530 billion or US$7.5 billion in 2019), making it India’s 42nd largest publicly traded company by market value.

On 23 April 2019, Cipla appointed Dr. Raju Mistry as Global Chief People Officer

It was founded by Khwaja Abdul Hamied as ‘The Chemical, Industrial & Pharmaceutical Laboratories’ in 1935 in Mumbai. The name of the Company was changed to ‘Cipla Limited’ on 20 July 1984. In the year 1985, the US FDA approved the company’s bulk drug manufacturing facilities. Led by the founder’s son Yusuf Hamied, a Cambridge-educated chemist, the company provided generic AIDS and other drugs to treat poor people in the developing world. In 1995, Cipla launched Deferiprone, the world’s first oral iron chelator. In 2001, Cipla offered medicines (antiretrovirals) for HIV treatment at a fractional cost (less than $350 per year per patient).